Latest Health News from Duke Medicine News and Communications
Study of 81,000 Adults Examines Mental Illness, Gun Violence and Suicide
June 6, 2016
People with serious mental illnesses who use guns to commit suicide are often legally eligible to purchase guns, despite having a past record of an involuntary mental health examination and brief hospitalization, according to a new Duke Health analysis.
Duke’s Poliovirus Therapy Shows Survival Benefit in Early Patients
June 6, 2016
An early group of patients who received a modified form of the poliovirus to treat recurrent glioblastoma brain tumors showed survival improvement over historical controls, according to researchers at the Preston Robert Tisch Brain Tumor Center at Duke Health.
Cancer Patients with ACA Policies Swiftly Reach Out-of-Pocket Caps
June 4, 2016
A hypothetical leukemia patient buying the life-extending drug therapy for his condition would reach his annual out-of-pocket maximum in a month on most of the bronze policies and half of the silver policies offered through the Affordable Care Act marketplace.
Duke Among Sites to Train First Responders On Infectious Disease Safety
June 2, 2016
Duke Health is one of eight sites nationally selected to participate in a program to help train first responders and other workers in properly handling infectious disease emergencies.
Scientists Block Breast Cancer Cells From Hiding in Bones
May 25, 2016
Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them.
Duke’s Poliovirus Therapy Wins “Breakthrough” Status to Expedite Research
May 16, 2016
The recombinant poliovirus therapy developed at the Preston Robert Tisch Brain Tumor Center at Duke Health has been granted “breakthrough therapy designation” from the U.S. Food and Drug Administration.
Bioengineered Blood Vessel Appears Safe for Dialysis Patients
May 12, 2016
Man-made blood vessels developed by researchers at Duke University, Yale University and the tissue engineering company Humacyte appear to be both safe and more durable than commonly used synthetic versions in patients undergoing kidney dialysis, the researchers report.
Mouse Model of Autism Offers Insights to Human Patients, Potential Drug Targets
May 10, 2016
A new mouse model of a genetically-linked type of autism reveals more about the role of genes in the disorder and the underlying brain changes associated with autism’s social and learning problems.
Study Seeks Women’s Insights on What Works Best for Uterine Fibroids
May 9, 2016
A new registry that launches this month gives women who have uterine fibroids the opportunity to help determine which strategies are most effective in treating the common condition.
Antibody Appears to Attack Cancer Cells, Leaving Other Cells Unscathed
May 5, 2016
A research team from Duke Health has developed an antibody from the body’s own immune system that preferentially attacks cancer cells. The antibody works by targeting a natural defense mechanism that cancer tumors exploit.